Artemisinin B improved learning and memory impairment in AD mice with dementia by suppressing neuroinflammation by reducing the gene expression levels of MyD88 and NF-κB as well as by reducing the protein levels of TLR4 and MyD88 [53]. Here, NFKB1 is linked to Alzheimer disease.